(Post-pandemic Era)-Global Drugs for Schistosomiasis Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2023

Report ID: 270424 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Drugs for Schistosomiasis Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Praziquantel -Product Introduction and Major Manufacturers
      1.1.2 Oxamniquine -Product Introduction and Major Manufacturers
      1.1.3 Other -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2020-2027)
    2.2 Regional Market Share in Terms of Revenue (2020-2027)
    2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Drugs for Schistosomiasis Market Assessment by Type
    3.1 Global Drugs for Schistosomiasis Production by Type (2016-2027)
    3.2 Global Drugs for Schistosomiasis Revenue by Type (2016-2027)
    3.3 North America Drugs for Schistosomiasis Production and Revenue by Type (2016-2027)
    3.4 Asia Drugs for Schistosomiasis Production and Revenue by Type (2016-2027)
    3.5 Europe Drugs for Schistosomiasis Production and Revenue by Type (2016-2027)
    3.6 Middle East & Africa Drugs for Schistosomiasis Production and Revenue by Type (2016-2027)
    3.7 South America Drugs for Schistosomiasis Production and Revenue by Type (2016-2027)

4 Global Drugs for Schistosomiasis Market Assessment by Application
    4.1 Historical & Forecast Global Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)
    4.2 Historical & Forecast North America Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)
    4.3 Historical & Forecast Asia Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)
    4.4 Historical & Forecast Europe Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)
    4.5 Historical & Forecast Middle East & Africa Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)
    4.6 Historical & Forecast South America Drugs for Schistosomiasis Consumption, Different Application Field (2016-2027)

5 North America
    5.1 US Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.2 Canada Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.3 Mexico Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
    6.1 China Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.2 Japan Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.3 India Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.4 Korea Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.5 Southeat Asia Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
    7.1 Germany Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.2 UK Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.3 France Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.4 Russia Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.5 Italy Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
    8.1 Saudi Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.2 UAE Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.3 Egypt Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.4 Nigeria Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.5 South Africa Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
    9.1 Brazil Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.2 Argentina Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.3 Colombia Drugs for Schistosomiasis Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Drugs for Schistosomiasis Average Price Trend
    10.1 Market Price for Each Type of Drugs for Schistosomiasis in North America (2016-2027)
    10.2 Market Price for Each Type of Drugs for Schistosomiasis in Asia (2016-2027)
    10.3 Market Price for Each Type of Drugs for Schistosomiasis in Europe (2016-2027)
    10.4 Market Price for Each Type of Drugs for Schistosomiasis in Middle East & Africa (2016-2027)
    10.5 Market Price for Each Type of Drugs for Schistosomiasis in South America (2016-2027)

11 Value Chain (Impact of COVID-19)
    11.1 Drugs for Schistosomiasis Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Drugs for Schistosomiasis Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Drugs for Schistosomiasis Competitive Analysis
     12.1 Shin Poong
        12.1.1 Shin Poong Company Profiles
        12.1.2 Shin Poong Product Introduction
        12.1.3 Shin Poong Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Merck
        12.2.1 Merck Company Profiles
        12.2.2 Merck Product Introduction
        12.2.3 Merck Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Bayer
        12.3.1 Bayer Company Profiles
        12.3.2 Bayer Product Introduction
        12.3.3 Bayer Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 EIPICO
        12.4.1 EIPICO Company Profiles
        12.4.2 EIPICO Product Introduction
        12.4.3 EIPICO Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
        12.5.1 Chandra Bhagat Pharma Company Profiles
        12.5.2 Chandra Bhagat Pharma Product Introduction
        12.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Taj Pharmaceuticals
        12.6.1 Taj Pharmaceuticals Company Profiles
        12.6.2 Taj Pharmaceuticals Product Introduction
        12.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
    Figure Global Drugs for Schistosomiasis Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2016-2027)
    Table Regional Market Share in Terms of Production (2020-2027)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2020-2027)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure Global Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure Global Drugs for Schistosomiasis Production Market Share (%) by Type (2019 -2020)
    Table Global Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure Global Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Global Drugs for Schistosomiasis Revenue Market Share (%) by Type (2019-2020)
    Figure North America Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure North America Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure North America Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure North America Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Asia Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure Asia Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure Asia Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure Asia Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Europe Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure Europe Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure Europe Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure Europe Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Middle East & Africa Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure Middle East & Africa Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure Middle East & Africa Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Figure South America Drugs for Schistosomiasis Production (K Unit) by Type (2016-2027)
    Figure South America Drugs for Schistosomiasis Production (K Unit) and Growth Rate (2016-2027)
    Figure South America Drugs for Schistosomiasis Revenue (Million USD) by Type (2016-2027)
    Figure South America Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure North America Drugs for Schistosomiasis Consumption (K Unit) and Growth Rate (2016-2027)
    Figure North America Drugs for Schistosomiasis Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure Asia Drugs for Schistosomiasis Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Asia Drugs for Schistosomiasis Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure Europe Drugs for Schistosomiasis Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Europe Drugs for Schistosomiasis Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Drugs for Schistosomiasis Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Drugs for Schistosomiasis Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Figure South America Drugs for Schistosomiasis Consumption (K Unit) and Growth Rate (2016-2027)
    Figure South America Drugs for Schistosomiasis Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Drugs for Schistosomiasis Different Application Field Consumption (K Unit)
    Table US Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Drugs for Schistosomiasis Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in China
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in EU
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in USA
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in Japan
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in India
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Drugs for Schistosomiasis in South America
    Figure Value Chain Structure of Drugs for Schistosomiasis
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Drugs for Schistosomiasis
    Figure Cost Structure of Drugs for Schistosomiasis in 2020
    Table Distributors/Traders List
    Table Shin Poong Profiles
    Table Shin Poong Drugs for Schistosomiasis Product Introduction
    Figure Shin Poong Drugs for Schistosomiasis Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Shin Poong SWOT Analysis
    Table Merck Profiles
    Table Merck Drugs for Schistosomiasis Product Introduction
    Figure Merck Drugs for Schistosomiasis Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Merck SWOT Analysis
    Table Bayer Profiles
    Table Bayer Drugs for Schistosomiasis Product Introduction
    Figure Bayer Drugs for Schistosomiasis Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Bayer SWOT Analysis
    Table EIPICO Profiles
    Table EIPICO Drugs for Schistosomiasis Product Introduction
    Figure EIPICO Drugs for Schistosomiasis Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure EIPICO SWOT Analysis
    Table Chandra Bhagat Pharma Profiles
    Table Chandra Bhagat Pharma Drugs for Schistosomiasis Product Introduction
    Figure Chandra Bhagat Pharma Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Chandra Bhagat Pharma SWOT Analysis
    Table Taj Pharmaceuticals Profiles
    Table Taj Pharmaceuticals Drugs for Schistosomiasis Product Introduction
    Figure Taj Pharmaceuticals Drugs for Schistosomiasis Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Drugs for Schistosomiasis Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Drugs for Schistosomiasis Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Drugs for Schistosomiasis Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports